About: Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of masked immuno-oncology therapies. The company's pipeline includes XTX501, a bispecific PD-1 / masked IL-2, for patients with metastatic non-small cell lung cancer; Efarindodekin alfa, an investigational, masked IL-12, that is in Phase 2 clinical trial for patients with advanced solid tumors; and Vilastobart, an investigational tumor-activated, Fc-enhanced, high affinity binding anti-CTLA-4 monoclonal antibody. The company was founded in 2016 and is headquartered in Waltham, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $8.68 (+8.64%)
XLO NASDAQ Xilio Development Inc
Xilio Development Inc share price
XLO price activity
Last Price
$8.680
Change (24hr)
0.69 USD (8.64%)
Volume
24.45K
Volume (4w avg)
-
Open
$7.94
Day Range
$7.94 - $8.85
Previous Close
$7.99
Last Trade
03 Nov, 9:02 pm GMT+0
Delayed
03 Nov, 9:02 pm GMT+0
XLO price performance
Delayed
03 Nov, 9:02 pm GMT+0
XLO details
XLO Market Signals